Report cover image

GenomicTree Co Ltd (228760) - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Mar 29, 2024
Length 38 Pages
SKU # GBDT18694806

Description

Summary


GenomicTree Co Ltd (GenomicTree) is a medical device company. It develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic products. Its products are used in the detection of colorectal, lung and bladder cancer. GenomicTree's products include novel epigenetic biomarkers and non-invasive accurate cancer detection products. The company's other products comprise infectious disease detection products, genotypes detection products, methylation profiling systems, single tube products, oncology treatment products, and others. GenomicTree offers services such as assay development, clinical validation, gene expression microarray services, miRNA microarray, methylation microarray, pyrosequencing, methylation, and methylation assay services. The company caters to the pharmaceutical and diagnostic sectors. GenomicTree is headquartered in Daejeon, South Korea.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GenomicTree Co Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

38 Pages
GenomicTree Co Ltd Company Overview
GenomicTree Co Ltd Company Snapshot
GenomicTree Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
GenomicTree Co Ltd – Pipeline Analysis Overview
GenomicTree Co Ltd - Key Facts
GenomicTree Co Ltd - Major Products and Services
GenomicTree Co Ltd Pipeline Products by Development Stage
GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status
GenomicTree Co Ltd Pipeline Products Overview
AccuraDTect SARS-CoV-2 RT-qPCR Kit
AccuraDTect SARS-CoV-2 RT-qPCR Kit Product Overview
AccuraTect EGFR
AccuraTect EGFR Product Overview
AccuraTect-BRAF
AccuraTect-BRAF Product Overview
EarlyTect Bladder Cancer Test
EarlyTect Bladder Cancer Test Product Overview
EarlyTect Bladder Cancer Test Clinical Trial
EarlyTect Breast Cancer
EarlyTect Breast Cancer Product Overview
EarlyTect Cervical Cancer
EarlyTect Cervical Cancer Product Overview
EarlyTect Colon Cancer Test
EarlyTect Colon Cancer Test Product Overview
EarlyTect Colorectal Cancer
EarlyTect Colorectal Cancer Product Overview
EarlyTect Lung Cancer Test
EarlyTect Lung Cancer Test Product Overview
GTPlex Respiratory PyroSeq Assay
GTPlex Respiratory PyroSeq Assay Product Overview
Real-Time PCR Respiratory Virus Assay
Real-Time PCR Respiratory Virus Assay Product Overview
Screening Test - Cervical Cancer
Screening Test - Cervical Cancer Product Overview
GenomicTree Co Ltd - Key Competitors
GenomicTree Co Ltd - Key Employees
GenomicTree Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
GenomicTree Co Ltd, Recent Developments
Mar 20, 2024: Genomictree, ‘Earlytech-B’ Designated as Innovative Medical Device by Korea Food and Drug Administration
Dec 14, 2023: Genomictree Completes Recruiting Patients for Bladder Cancer Early Detection Trials
May 31, 2023: Genomictree launches LDT service for its bladder cancer diagnostic in US
May 01, 2023: Promis gets breakthrough device status from FDA for EarlyTect BCD test
Apr 27, 2023: Genomictree's bladder cancer diagnostic kit receives breakthrough device designation from FDA
Sep 10, 2021: Promis Dx presents validation data for urine DNA test for bladder cancer detection in Hematuria
Dec 31, 2020: Daewoong Pharmaceutical Company Indonesia (DPCI) acquires a license to sell COVID-19 Test kit in Indonesia
Jun 07, 2013: Biomarker Identification May Lead To New Noninvasive Test For Colorectal Cancer Detection, Yonsei University College of Medicine And Genomictree Study
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: GenomicTree Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: GenomicTree Co Ltd Pipeline Products by Equipment Type
Table 3: GenomicTree Co Ltd Pipeline Products by Indication
Table 4: GenomicTree Co Ltd, Key Facts
Table 5: GenomicTree Co Ltd, Major Products and Services
Table 6: GenomicTree Co Ltd Number of Pipeline Products by Development Stage
Table 7: GenomicTree Co Ltd Pipeline Products Summary by Development Stage
Table 8: GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status
Table 9: GenomicTree Co Ltd Ongoing Clinical Trials Summary
Table 10: AccuraDTect SARS-CoV-2 RT-qPCR Kit - Product Status
Table 11: AccuraDTect SARS-CoV-2 RT-qPCR Kit - Product Description
Table 12: AccuraTect EGFR - Product Status
Table 13: AccuraTect EGFR - Product Description
Table 14: AccuraTect-BRAF - Product Status
Table 15: AccuraTect-BRAF - Product Description
Table 16: EarlyTect Bladder Cancer Test - Product Status
Table 17: EarlyTect Bladder Cancer Test - Product Description
Table 18: EarlyTect Bladder Cancer Test - A Multicenter, Single-blind, Prospective Clinical Trial to Evaluate the Clinical Performance of EarlyTect Bladder Cancer Test in the Urine DNA for Detecting Bladder Cancer Among Hematuria Patients
Table 19: EarlyTect Breast Cancer - Product Status
Table 20: EarlyTect Breast Cancer - Product Description
Table 21: EarlyTect Cervical Cancer - Product Status
Table 22: EarlyTect Cervical Cancer - Product Description
Table 23: EarlyTect Colon Cancer Test - Product Status
Table 24: EarlyTect Colon Cancer Test - Product Description
Table 25: EarlyTect Colorectal Cancer - Product Status
Table 26: EarlyTect Colorectal Cancer - Product Description
Table 27: EarlyTect Lung Cancer Test - Product Status
Table 28: EarlyTect Lung Cancer Test - Product Description
Table 29: GTPlex Respiratory PyroSeq Assay - Product Status
Table 30: GTPlex Respiratory PyroSeq Assay - Product Description
Table 31: Real-Time PCR Respiratory Virus Assay - Product Status
Table 32: Real-Time PCR Respiratory Virus Assay - Product Description
Table 33: Screening Test - Cervical Cancer - Product Status
Table 34: Screening Test - Cervical Cancer - Product Description
Table 35: GenomicTree Co Ltd, Key Employees
Table 36: GenomicTree Co Ltd, Subsidiaries
Table 37: Glossary
List of Figures
Figure 1: GenomicTree Co Ltd Pipeline Products by Equipment Type
Figure 2: GenomicTree Co Ltd Pipeline Products by Development Stage
Figure 3: GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us